Skip to main content

Table 3 Cox analysis of risk factors associated with recurrence

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Characteristics Univariable Multivariable
HR 95% CI p value HR 95%CI p value
Age (years) 1.105 0.965–1.241 0.314  
BMI (kg/m2) 1.165 0.823–1.284 0.287
SBP (mmHg) 1.112 0.963–1.323 0.432
DBP (mmHg) 1.223 0.932–1.444 0.642
Triglycerides (mmol/L) 1.013 0.862–1.152 0.426
HDL (mmol/L) 1.104 1.013–1.324 0.023* 1.312 0.913–1.632 0.452
LDL (mmol/L) 1.342 0.982–1.552 0.313  
Fasting glucose (mmol/L) 1.122 0.951–1.302 0.524
CEA (ng/ml) 1.123 1.032–1.452 0.014* 1.127 0.972–1.516 0.292
Differentiation 0.882 0.823–0.965 0.009* 0.904 0.832–1.176 0.128
Location 1.302 0.921–1.542 0.392  
 Ascending, transverse, and descending 1.000
 Sigmoid 1.242 0.927–1.423 0.542
 Rectum 1.132 0.912–1.402 0.356
Stage 1.322 1.095–1.932 0.011* 1.522 1.312–1.923 0.008*
 I 1.000 1.000
 II 1.092 0.902–1.123 0.223 1.223 0.922–1.433 0.321
 III 2.123 1.232–2.873 0.001* 1.923 1.321–2.923 0.001*
MetS 1.722 1.224–2.722 0.020* 1.821 1.164–3.121 0.010*
NAFLD 1.542 0.935–2.226 0.109  
 Non 1.000
 Mild 1.097 0.913–1.198 0.312
 Moderate 1.431 0.921–2.216 0.197
 Severe 1.582 0.945–2.368 0.210
  1. NAFLD, non-alcoholic fatty livers disease, MetS metabolic syndrome, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. *represent the p value ≤ 0.05